Skip to main content
. 2020 May 1;318(6):H1487–H1508. doi: 10.1152/ajpheart.00709.2019

Table 2.

Expression of genes that were partially normalized in CBK hearts following SR-9009 administration for 8 days at ZT9

ENSEMBL ID Gene Description CBK Vehicle vs. CON Vehicle (Fold Change), CBK SR-9009 vs. CBK Vehicle
(Fold Change)
Up in CBK vehicle ≥ 2.0-fold Down in CBK SR-9009 ≤ −2.0-fold
ENSMUSG00000101144 Predicted gene 29054 5.6 −3.7
ENSMUSG00000098194 Predicted gene 7286 4.4 −2.4
ENSMUSG00000024211 Glutamate receptor, metabotropic 8 3.2 −2.1
ENSMUSG00000044322 Desmocollin 1 3.1 −2.2
Down in CBK vehicle up to −2.0-Fold Up in CBK SR-9009 ≥ 2.0-Fold
ENSMUSG00000041771 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 −2.9 2.1
ENSMUSG00000008932 Solute carrier family 1 (glutamate transporter), member 7 −3.5 2.6
ENSMUSG00000085965 RIKEN cDNA 2310016D23 gene −3.6 2.4
ENSMUSG00000092051 Predicted gene 17229 −3.7 2.2
ENSMUSG00000016179 Calcium/calmodulin-dependent protein kinase I gamma −3.8 2.0
ENSMUSG00000073399 Tripartite motif-containing 40 −4.0 2.6
ENSMUSG00000086935 Predicted gene 15956 −4.5 2.0
ENSMUSG00000044405 Adipogenin −4.6 2.0
ENSMUSG00000105867 Predicted gene 42517 −4.6 2.2
ENSMUSG00000025481 Urate (5-hydroxyiso-) hydrolase −4.8 2.3
ENSMUSG00000026358 Regulator of G protein signaling 1 −5.1 2.5
ENSMUSG00000050071 Brain expressed X-linked 1 −5.7 2.2
ENSMUSG00000030336 CD27 antigen −6.0 3.4
ENSMUSG00000030483 Cytochrome P450, family 2, subfamily b, polypeptide 10 −6.1 2.5
ENSMUSG00000043999 G protein-coupled receptor 75 −6.1 2.5
ENSMUSG00000061718 Protein phosphatase 1, regulatory inhibitor subunit 1B −7.0 2.1
ENSMUSG00000051811 Cytochrome c oxidase subunit 6B2 −7.7 2.1
ENSMUSG00000086645 Predicted gene 15743 −9.0 2.5
ENSMUSG00000103476 Predicted gene, 34302 −9.1 2.1
ENSMUSG00000079620 Mucin 4 −11.4 2.1
ENSMUSG00000050423 Protein phosphatase 1, regulatory subunit 3G −18.6 2.0
ENSMUSG00000028307 Aldolase B, fructose-bisphosphate −89.1 2.3

CBK, cardiomyocyte-specific BMAL1-knockout; CON, control; ZT9, zeitgeber time 9. Included are genes whose expression changed ≥2-fold in CBK vs. CON hearts (from vehicle-treated mice) and the same gene changed in the opposite direction ≥2-fold in CBK hearts following SR-9009 administration. RNA-seq data were used for this analysis.